Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
The latest available 13F covers holdings as of Jun 30, 2026 (Q2 2026) and was filed Aug 13, 2026. Quarter-end snapshot, not a live trade.
Disclosed 13F value
$9.24B
sum of reported positions
Reported positions
122
Changes vs prior quarter
113
23 new · 8 exited
Filings on record
9
Q2 2026, Q1 2026, Q4 2025, Q3 2025, Q2 2025, Q1 2025, Q4 2024, Q3 2024, Q2 2024
Across 264 measured positions in 8 quarters, the typical new or larger position finished −1.0 pts against the S&P 500 and 47% finished ahead of it. For scale, across all 501 funds with a result: −2.2 pts typical, 44% ahead.
Measured on each position this fund reported as new or larger, from the first close after the filing became public, against the S&P 500, 90 days later. Sales are not scored. History, not a forecast; it shows what the stocks did, not what the fund knew.
Total value of the 13F each quarter. It moves with prices as well as with what the fund bought or sold, so a rise is not necessarily a purchase.
| Company | Shares | Value | Weight |
|---|---|---|---|
| 9.36M | $1.75B | 19.0% | |
| 41.2M | $1.18B | 12.7% | |
| 29.4M | $994M | 10.8% | |
Comparison uses this manager's immediately preceding 13F-HR. Puts and calls are separate lines. Share counts drive classification; reported value also moves with price.Methodology
Change in the reported value against the quarter before.
Weights are within the disclosed 13F portfolio, for the ten largest lines.
| Q1 2026 | Q2 2026 | |
|---|---|---|
| Reported value | $8.15B | $9.24B |
| Positions | 107 | 122 |
| Biggest line | — | Astrazeneca 19% |
| 15M |
| $696M |
| 7.5% |
| 6.71M | $582M | 6.3% |
| 532K | $254M | 2.8% |
| 3.18M | $166M | 1.8% |
| 2.18M | $160M | 1.7% |
| 706K | $129M | 1.4% |
| 955K | $123M | 1.3% |
| 201K | $113M | 1.2% |
| 316K | $112M | 1.2% |
| 3.98M | $107M | 1.2% |
| 255K | $99.5M | 1.1% |
| 630K | $97.1M | 1.1% |
| 995K | $95.5M | 1.0% |
| 860K | $92.4M | 1.0% |
| 253K | $90.3M | 1.0% |
| 1.03M | $84.8M | 0.9% |
| 3.06M | $83.3M | 0.9% |
| 1.68M | $80.4M | 0.9% |
| 248K | $76.9M | 0.8% |
| 1.08M | $75.5M | 0.8% |
| 572K | $73.3M | 0.8% |
| 899K | $72.3M | 0.8% |
Astrazeneca (AZN)
7.42M → 9.36M shares (+26%)
Deutsche Bank Aktiengesellschaft (DB)
25M → 29.4M shares (+18%)
Taiwan Semiconductor Manufacturing (TSM)
508K → 532K shares (+5%)
Alaska Air Group (ALK)
2.5M → 3.18M shares (+27%)
Carrier Global (CARR)
2.1M → 2.18M shares (+4%)
Live Nation Entertainment (LYV)
526K → 706K shares (+34%)
Merck (MRK)
854K → 955K shares (+12%)
Meta (META)
145K → 201K shares (+39%)
Credicorp (BAP)
245K → 255K shares (+4%)
SAP (SAP)
456K → 630K shares (+38%)
Axis Capital Holdings (AXS)
816K → 860K shares (+5%)
Everest Group (EG)
250K → 253K shares (+1%)
Ingersoll Rand (IR)
626K → 1.03M shares (+65%)
Koninklijke Philips (PHG)
2.46M → 3.06M shares (+25%)
Novo Nordisk (NVO)
1.17M → 1.68M shares (+43%)
Jones Lang LaSalle (JLL)
186K → 248K shares (+33%)
Citizens Financial Group (CFG)
1.05M → 1.08M shares (+3%)
Diageo (DEO)
666K → 899K shares (+35%)
Natwest Group (NWG)
2.99M → 3.49M shares (+17%)
Gold Fields (GFI)
1.63M → 1.71M shares (+5%)
Ing Groep (ING)
1.54M → 1.69M shares (+10%)
National Grid (NGG)
539K → 590K shares (+10%)
PETROLEO BRASILEIRO SA - PETROBRAS
1.5M → 3.1M shares (+107%)
Prudential (PUK)
1.32M → 1.69M shares (+28%)
Smith & Nephew (SNN)
953K → 1.57M shares (+64%)
